[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$mbrx](/topic/$mbrx) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$MBRX CEO with major purchase after the last round. His largest purchase to date" [X Link](https://x.com/zay111086718/status/1979200245532660138) [@zay111086718](/creator/x/zay111086718) 2025-10-17T14:58Z XXX followers, XXX engagements "$MBRX ⚙ Accumulation Phase Active Phase X enrollment expanding price holding key support. Quiet accumulation ahead of Q4 trial updates eyes on volume. Im guiding this stock live inside my group right now. 👉" [X Link](https://x.com/SANJKUMI/status/1978806648203248066) [@SANJKUMI](/creator/x/SANJKUMI) 2025-10-16T12:54Z XX followers, XX engagements "$MBRX 💉 Clinical Momentum Building Global recruitment for the Phase X MIRACLE AML trial expanding fast aiming for XX patients by Q4 as survival data outperforms peers. Im guiding this stock live inside my group right now. 👉" [X Link](https://x.com/RiskRebelGrace/status/1978806479462265319) [@RiskRebelGrace](/creator/x/RiskRebelGrace) 2025-10-16T12:53Z XXX followers, XX engagements "Beyond Annamycin $MBRX boasts a robust pipeline tackling hard-to-treat tumors and viruses. WP1066 a STAT3 inhibitor is in Phase X for glioblastoma and other brain cancers showing promise in immune modulation. WP1220 targets atopic dermatitis while antiviral candidates like WP1096 aim at threats like Ebola. But Annamycin steals the showoriginally developed at MD Anderson the worlds top research cancer center and licensed to Moleculin in 2016. With composition patents in US Europe Canada and China extending to 2040+ this pipeline positions $MBRX as a multi-asset acquisition target" [X Link](https://x.com/zay111086718/status/1978794517059772824) [@zay111086718](/creator/x/zay111086718) 2025-10-16T12:05Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$MBRX CEO with major purchase after the last round. His largest purchase to date"
X Link @zay111086718 2025-10-17T14:58Z XXX followers, XXX engagements
"$MBRX ⚙ Accumulation Phase Active Phase X enrollment expanding price holding key support. Quiet accumulation ahead of Q4 trial updates eyes on volume. Im guiding this stock live inside my group right now. 👉"
X Link @SANJKUMI 2025-10-16T12:54Z XX followers, XX engagements
"$MBRX 💉 Clinical Momentum Building Global recruitment for the Phase X MIRACLE AML trial expanding fast aiming for XX patients by Q4 as survival data outperforms peers. Im guiding this stock live inside my group right now. 👉"
X Link @RiskRebelGrace 2025-10-16T12:53Z XXX followers, XX engagements
"Beyond Annamycin $MBRX boasts a robust pipeline tackling hard-to-treat tumors and viruses. WP1066 a STAT3 inhibitor is in Phase X for glioblastoma and other brain cancers showing promise in immune modulation. WP1220 targets atopic dermatitis while antiviral candidates like WP1096 aim at threats like Ebola. But Annamycin steals the showoriginally developed at MD Anderson the worlds top research cancer center and licensed to Moleculin in 2016. With composition patents in US Europe Canada and China extending to 2040+ this pipeline positions $MBRX as a multi-asset acquisition target"
X Link @zay111086718 2025-10-16T12:05Z XXX followers, XXX engagements
/topic/$mbrx/posts